翻訳と辞書 |
Ablynx
Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies. ==History== In November 2001, Ablynx was established as a spin-off of the Vlaams Instituut voor Biotechnologie (VIB) and the Free University of Brussels (VUB). Seed financing of €2M was provided by Gimv.〔(Ablynx.com - History )〕 In July 2015 Merck & Co. and Ablynx expanded their 18 month old immuno-oncology collaboration by four years, generating a potential $4.4 billion in milestone payments for Ablynx.〔http://www.genengnews.com/gen-news-highlights/ablynx-merck-co-ink-4b-expansion-of-immuno-oncology-collaboration/81251532/〕 In 2015, the Novo Nordisk announced it would collaborate with Ablynx, using its nanobody technology to develop at least one new drug candidate, generating a potential $400 million for the company.〔http://www.genengnews.com/gen-news-highlights/novo-nordisk-joins-ablynx-in-up-to-399m-nanobody-alliance/81252025/〕
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Ablynx」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|